WO2022157745A1 - Multi micro-nutrient (mmn): composition for pregnancy - Google Patents
Multi micro-nutrient (mmn): composition for pregnancy Download PDFInfo
- Publication number
- WO2022157745A1 WO2022157745A1 PCT/IB2022/050634 IB2022050634W WO2022157745A1 WO 2022157745 A1 WO2022157745 A1 WO 2022157745A1 IB 2022050634 W IB2022050634 W IB 2022050634W WO 2022157745 A1 WO2022157745 A1 WO 2022157745A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- vitamin
- composition
- mcg
- lomg
- trimester
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 92
- 230000035935 pregnancy Effects 0.000 title abstract description 56
- 239000011785 micronutrient Substances 0.000 title abstract description 20
- 235000013369 micronutrients Nutrition 0.000 title abstract description 18
- 229940088594 vitamin Drugs 0.000 claims abstract description 91
- 239000011782 vitamin Substances 0.000 claims abstract description 91
- 229930003231 vitamin Natural products 0.000 claims abstract description 88
- 235000013343 vitamin Nutrition 0.000 claims abstract description 88
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 20
- 239000011707 mineral Substances 0.000 claims abstract description 20
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 76
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 68
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 38
- 229910052742 iron Inorganic materials 0.000 claims description 38
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 36
- 229960003284 iron Drugs 0.000 claims description 32
- 239000011777 magnesium Substances 0.000 claims description 27
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 26
- 239000010949 copper Substances 0.000 claims description 26
- 229910052802 copper Inorganic materials 0.000 claims description 26
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 25
- 239000011669 selenium Substances 0.000 claims description 25
- 229910052711 selenium Inorganic materials 0.000 claims description 25
- 235000011649 selenium Nutrition 0.000 claims description 25
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 24
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 24
- 229910052749 magnesium Inorganic materials 0.000 claims description 24
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 24
- 239000011701 zinc Substances 0.000 claims description 24
- 229910052725 zinc Inorganic materials 0.000 claims description 24
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 22
- 239000011575 calcium Substances 0.000 claims description 21
- 229910052791 calcium Inorganic materials 0.000 claims description 21
- 235000019155 vitamin A Nutrition 0.000 claims description 21
- 239000011719 vitamin A Substances 0.000 claims description 21
- 235000019154 vitamin C Nutrition 0.000 claims description 21
- 239000011718 vitamin C Substances 0.000 claims description 21
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims description 20
- 229910052796 boron Inorganic materials 0.000 claims description 20
- 235000019165 vitamin E Nutrition 0.000 claims description 20
- 239000011709 vitamin E Substances 0.000 claims description 20
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 19
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 19
- 229930003268 Vitamin C Natural products 0.000 claims description 19
- 229910052748 manganese Inorganic materials 0.000 claims description 19
- 239000011572 manganese Substances 0.000 claims description 19
- 235000002908 manganese Nutrition 0.000 claims description 19
- 229930003427 Vitamin E Natural products 0.000 claims description 18
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 18
- 229940046009 vitamin E Drugs 0.000 claims description 16
- 235000019168 vitamin K Nutrition 0.000 claims description 15
- 239000011712 vitamin K Substances 0.000 claims description 15
- 229930003448 Vitamin K Natural products 0.000 claims description 14
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 14
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 14
- 229940046010 vitamin k Drugs 0.000 claims description 14
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 13
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 13
- 239000011630 iodine Substances 0.000 claims description 13
- 229910052740 iodine Inorganic materials 0.000 claims description 13
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 12
- 229910052804 chromium Inorganic materials 0.000 claims description 12
- 239000011651 chromium Substances 0.000 claims description 12
- 229960003512 nicotinic acid Drugs 0.000 claims description 12
- 229940011671 vitamin b6 Drugs 0.000 claims description 12
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 11
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 11
- 239000011733 molybdenum Substances 0.000 claims description 11
- 229910052750 molybdenum Inorganic materials 0.000 claims description 11
- 235000019158 vitamin B6 Nutrition 0.000 claims description 11
- 239000011726 vitamin B6 Substances 0.000 claims description 11
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 10
- 229930003537 Vitamin B3 Natural products 0.000 claims description 9
- 229930003756 Vitamin B7 Natural products 0.000 claims description 9
- 239000004615 ingredient Substances 0.000 claims description 9
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 9
- 235000019160 vitamin B3 Nutrition 0.000 claims description 9
- 239000011708 vitamin B3 Substances 0.000 claims description 9
- 235000011912 vitamin B7 Nutrition 0.000 claims description 9
- 239000011735 vitamin B7 Substances 0.000 claims description 9
- 206010010774 Constipation Diseases 0.000 claims description 8
- 235000001014 amino acid Nutrition 0.000 claims description 8
- 150000001413 amino acids Chemical class 0.000 claims description 8
- 235000015872 dietary supplement Nutrition 0.000 claims description 8
- 239000006041 probiotic Substances 0.000 claims description 8
- 235000018291 probiotics Nutrition 0.000 claims description 8
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 7
- 229940024606 amino acid Drugs 0.000 claims description 7
- 230000003474 anti-emetic effect Effects 0.000 claims description 7
- 239000002111 antiemetic agent Substances 0.000 claims description 7
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 7
- 229960001231 choline Drugs 0.000 claims description 7
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 7
- 229960000367 inositol Drugs 0.000 claims description 7
- 235000013406 prebiotics Nutrition 0.000 claims description 7
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 7
- 230000001062 anti-nausea Effects 0.000 claims description 6
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 6
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 6
- 239000000969 carrier Substances 0.000 claims description 5
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 208000019206 urinary tract infection Diseases 0.000 claims description 4
- 229960005069 calcium Drugs 0.000 claims description 3
- 230000001079 digestive effect Effects 0.000 claims description 3
- 235000010755 mineral Nutrition 0.000 abstract description 15
- 238000009472 formulation Methods 0.000 abstract description 7
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 27
- 235000019152 folic acid Nutrition 0.000 description 19
- 239000011724 folic acid Substances 0.000 description 19
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 16
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 15
- 229940091250 magnesium supplement Drugs 0.000 description 15
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 14
- 230000009469 supplementation Effects 0.000 description 14
- 229940045997 vitamin a Drugs 0.000 description 14
- 235000019166 vitamin D Nutrition 0.000 description 13
- 239000011710 vitamin D Substances 0.000 description 13
- 239000003963 antioxidant agent Substances 0.000 description 12
- 235000006708 antioxidants Nutrition 0.000 description 12
- 230000007812 deficiency Effects 0.000 description 12
- 238000011161 development Methods 0.000 description 12
- 229940014144 folate Drugs 0.000 description 12
- 229930003316 Vitamin D Natural products 0.000 description 11
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 11
- 230000018109 developmental process Effects 0.000 description 11
- 150000003710 vitamin D derivatives Chemical class 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 235000019156 vitamin B Nutrition 0.000 description 10
- 239000011720 vitamin B Substances 0.000 description 10
- 229940046008 vitamin d Drugs 0.000 description 10
- 238000010521 absorption reaction Methods 0.000 description 9
- 230000003078 antioxidant effect Effects 0.000 description 9
- 230000002950 deficient Effects 0.000 description 9
- 235000005911 diet Nutrition 0.000 description 9
- 208000004104 gestational diabetes Diseases 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 235000016709 nutrition Nutrition 0.000 description 8
- 208000007101 Muscle Cramp Diseases 0.000 description 7
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 210000000988 bone and bone Anatomy 0.000 description 7
- 210000004556 brain Anatomy 0.000 description 7
- 229960000304 folic acid Drugs 0.000 description 7
- 230000036541 health Effects 0.000 description 7
- 201000011461 pre-eclampsia Diseases 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 239000003826 tablet Substances 0.000 description 7
- 229940046001 vitamin b complex Drugs 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 6
- 208000007502 anemia Diseases 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 208000032170 Congenital Abnormalities Diseases 0.000 description 5
- 206010020772 Hypertension Diseases 0.000 description 5
- 230000004641 brain development Effects 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 230000000378 dietary effect Effects 0.000 description 5
- 210000003754 fetus Anatomy 0.000 description 5
- 230000008774 maternal effect Effects 0.000 description 5
- 201000010193 neural tube defect Diseases 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 235000003715 nutritional status Nutrition 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 208000035581 susceptibility to neural tube defects Diseases 0.000 description 5
- 230000036642 wellbeing Effects 0.000 description 5
- 208000009233 Morning Sickness Diseases 0.000 description 4
- 208000034850 Vomiting in pregnancy Diseases 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000007698 birth defect Effects 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 235000020802 micronutrient deficiency Nutrition 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000036542 oxidative stress Effects 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 210000001685 thyroid gland Anatomy 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 235000013311 vegetables Nutrition 0.000 description 4
- 206010010356 Congenital anomaly Diseases 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- 206010016100 Faeces discoloured Diseases 0.000 description 3
- 206010028813 Nausea Diseases 0.000 description 3
- 208000001132 Osteoporosis Diseases 0.000 description 3
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 3
- 206010047626 Vitamin D Deficiency Diseases 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000011132 hemopoiesis Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 229940064128 l-methylfolate Drugs 0.000 description 3
- 235000007635 levomefolic acid Nutrition 0.000 description 3
- 239000011578 levomefolic acid Substances 0.000 description 3
- ZNOVTXRBGFNYRX-ABLWVSNPSA-N levomefolic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 ZNOVTXRBGFNYRX-ABLWVSNPSA-N 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 208000018773 low birth weight Diseases 0.000 description 3
- 231100000533 low birth weight Toxicity 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000008693 nausea Effects 0.000 description 3
- 210000000653 nervous system Anatomy 0.000 description 3
- 239000002858 neurotransmitter agent Substances 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 239000011664 nicotinic acid Substances 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 235000019157 thiamine Nutrition 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 3
- 239000011721 thiamine Substances 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 235000019163 vitamin B12 Nutrition 0.000 description 3
- 239000011715 vitamin B12 Substances 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 206010015137 Eructation Diseases 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- 208000001362 Fetal Growth Retardation Diseases 0.000 description 2
- 206010016849 Foetal complications Diseases 0.000 description 2
- 206010070531 Foetal growth restriction Diseases 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 206010071602 Genetic polymorphism Diseases 0.000 description 2
- 206010067997 Iodine deficiency Diseases 0.000 description 2
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 2
- 240000007472 Leucaena leucocephala Species 0.000 description 2
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 201000009916 Postpartum depression Diseases 0.000 description 2
- 208000002787 Pregnancy Complications Diseases 0.000 description 2
- 208000005107 Premature Birth Diseases 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 229930003779 Vitamin B12 Natural products 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- 235000006886 Zingiber officinale Nutrition 0.000 description 2
- 208000024330 bloating Diseases 0.000 description 2
- 230000014461 bone development Effects 0.000 description 2
- 230000037180 bone health Effects 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical group [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000018823 dietary intake Nutrition 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000008175 fetal development Effects 0.000 description 2
- 208000030941 fetal growth restriction Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 229940014259 gelatin Drugs 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 235000008397 ginger Nutrition 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 235000006479 iodine deficiency Nutrition 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 230000011987 methylation Effects 0.000 description 2
- 238000007069 methylation reaction Methods 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 210000000944 nerve tissue Anatomy 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 208000012113 pregnancy disease Diseases 0.000 description 2
- 235000008160 pyridoxine Nutrition 0.000 description 2
- 239000011677 pyridoxine Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000006128 skin development Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000005495 thyroid hormone Substances 0.000 description 2
- 229940036555 thyroid hormone Drugs 0.000 description 2
- 230000025366 tissue development Effects 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 235000019159 vitamin B9 Nutrition 0.000 description 2
- 239000011727 vitamin B9 Substances 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 239000001841 zingiber officinale Substances 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- TZBGSHAFWLGWBO-ABLWVSNPSA-N (2s)-2-[[4-[(2-amino-4-oxo-5,6,7,8-tetrahydro-1h-pteridin-6-yl)methylamino]benzoyl]amino]-5-methoxy-5-oxopentanoic acid Chemical compound C1=CC(C(=O)N[C@@H](CCC(=O)OC)C(O)=O)=CC=C1NCC1NC(C(=O)NC(N)=N2)=C2NC1 TZBGSHAFWLGWBO-ABLWVSNPSA-N 0.000 description 1
- DTCCVIYSGXONHU-CJHDCQNGSA-N (z)-2-(2-phenylethenyl)but-2-enedioic acid Chemical compound OC(=O)\C=C(C(O)=O)\C=CC1=CC=CC=C1 DTCCVIYSGXONHU-CJHDCQNGSA-N 0.000 description 1
- MRAKLTZPBIBWFH-ARJAWSKDSA-N (z)-2-ethenylbut-2-enedioic acid Chemical compound OC(=O)\C=C(\C=C)C(O)=O MRAKLTZPBIBWFH-ARJAWSKDSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 208000021959 Abnormal metabolism Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 206010002065 Anaemia megaloblastic Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010065687 Bone loss Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 240000000467 Carum carvi Species 0.000 description 1
- 235000005747 Carum carvi Nutrition 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 244000304337 Cuminum cyminum Species 0.000 description 1
- 235000007129 Cuminum cyminum Nutrition 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013710 Drug interaction Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 206010016880 Folate deficiency Diseases 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 206010070538 Gestational hypertension Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 201000005624 HELLP Syndrome Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000002972 Hepatolenticular Degeneration Diseases 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 101150019913 MTHFR gene Proteins 0.000 description 1
- 208000008167 Magnesium Deficiency Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000024873 Mentha crispa Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 1
- 206010027951 Mood swings Diseases 0.000 description 1
- 102000036675 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- CXOFVDLJLONNDW-UHFFFAOYSA-N Phenytoin Chemical compound N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 208000005347 Pregnancy-Induced Hypertension Diseases 0.000 description 1
- 206010036595 Premature delivery Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 240000004534 Scutellaria baicalensis Species 0.000 description 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 201000010829 Spina bifida Diseases 0.000 description 1
- 208000006097 Spinal Dysraphism Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 206010043275 Teratogenicity Diseases 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 208000010011 Vitamin A Deficiency Diseases 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003761 Vitamin B9 Natural products 0.000 description 1
- 201000000839 Vitamin K Deficiency Bleeding Diseases 0.000 description 1
- 206010047634 Vitamin K deficiency Diseases 0.000 description 1
- 208000018839 Wilson disease Diseases 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 239000010617 anise oil Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000004097 bone metabolism Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 230000003913 calcium metabolism Effects 0.000 description 1
- 229940069978 calcium supplement Drugs 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000004640 cellular pathway Effects 0.000 description 1
- 230000033077 cellular process Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229920001531 copovidone Polymers 0.000 description 1
- 235000020237 cranberry extract Nutrition 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 235000021112 essential micronutrients Nutrition 0.000 description 1
- 235000021321 essential mineral Nutrition 0.000 description 1
- 230000004578 fetal growth Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 235000002532 grape seed extract Nutrition 0.000 description 1
- 229940087603 grape seed extract Drugs 0.000 description 1
- 235000021384 green leafy vegetables Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 235000004280 healthy diet Nutrition 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 230000036446 length of gestation Effects 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000021073 macronutrients Nutrition 0.000 description 1
- 235000004764 magnesium deficiency Nutrition 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 229960003987 melatonin Drugs 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000001220 mentha spicata Substances 0.000 description 1
- 230000006371 metabolic abnormality Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000004220 muscle function Effects 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000021315 omega 9 monounsaturated fatty acids Nutrition 0.000 description 1
- 230000005305 organ development Effects 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 208000033300 perinatal asphyxia Diseases 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 229960002036 phenytoin Drugs 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 208000036335 preeclampsia/eclampsia 1 Diseases 0.000 description 1
- 230000009237 prenatal development Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000006884 regulation of angiogenesis Effects 0.000 description 1
- 230000014493 regulation of gene expression Effects 0.000 description 1
- 230000009712 regulation of translation Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 231100000378 teratogenic Toxicity 0.000 description 1
- 230000003390 teratogenic effect Effects 0.000 description 1
- 231100000211 teratogenicity Toxicity 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000021404 traditional food Nutrition 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 230000001457 vasomotor Effects 0.000 description 1
- 235000003563 vegetarian diet Nutrition 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 208000016794 vitamin K deficiency hemorrhagic disease Diseases 0.000 description 1
- 229940045999 vitamin b 12 Drugs 0.000 description 1
- 239000001717 vitis vinifera seed extract Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
- 229940093612 zein Drugs 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/22—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
Definitions
- MULTI MICRO-NUTRIENT MULTI MICRO-NUTRIENT (MMN); COMPOSITION FOR PREGNANCY
- the present invention relates to a novel Multi Micro -nutrient (MMN) formulation and trimester- wise system for pregnant women, especially, women in India.
- MNN Multi Micro -nutrient
- Nutritional intake during pregnancy not only determines growth and development of the fetus but also impacts the health of that child in his or her lifetime. In the baby, micronutrient deficiency during pregnancy, can lead to megaloblastosis, neural tube defects, placental and foetal defects, low birth weight and premature delivery. It has also been found that nutritional intake during pregnancy defines the mother’s well-being while she is pregnant as well as postdelivery. Nutritional deficiencies can cause various pregnancy symptoms such as gestational diabetes, preeclampsia, thyroid, leg cramps, insomnia, nausea, post-natal depression etc.; and can also lead to long-term issues in the mother such as osteoporosis, hypertension and diabetes.
- Vitamins and Minerals are commonly administered during pregnancy. The purpose is firstly, to treat micronutrient deficiencies in the pregnant woman; and secondly, to meet the increasing physiological demands by filling the gaps in her diet.
- Vitamin B complex composed of eight B vitamins- vitamins Bi (thiamine), B2 (riboflavin), B3 (niacin), Be (pyridoxine) and B12 (cyanocobalamin), which are water-soluble vitamins required for the production and release of energy in cells and for the metabolism of macronutrients. These vitamins act as coenzymes in a number of enzyme-dependent cellular intermediary metabolic pathways for energy generation and blood cell formation. Vitamin B12 and folate convert homocysteine to methionine that is essential for the methylation of DNA, RNA, proteins, neurotransmitters and phospholipids and deficiency in these vitamins can affect cellular growth and nerve tissue development.
- Bi thiamine
- B2 riboflavin
- B3 niacin
- Be pyridoxine
- B12 cyanocobalamin
- folate is a water-soluble B vitamin present in leafy green vegetables, yeast extract and citrus fruits such as oranges.
- Folic acid is most crucial in pregnancy from preconception until at least 12 weeks. Supplementation of folic acid during preconception and early pregnancy is critical and can prevent 40-80% of neural tube defects (NTDs) such as spina bifida.
- NTDs neural tube defects
- the dietary folic acid is converted to acid to L- methylfolate in the body through a number of enzymatic reactions and lastly using enzyme methyl-tetrahydrofolate reductase (MTHFR) before it can be absorbed by the body.
- MTHFR methyl-tetrahydrofolate reductase
- Iron is another important micro -nutrient which is involved in number of important cellular processes. Iron is involved in synthesis of haemoglobin and myoglobin, including oxygen transport, respiration, growth, gene regulation, and the proper functioning of iron-dependent enzymes. Anaemia has been estimated to affect 40% of pregnant women globally, with the highest prevalence in the regions of South-east Asia (49%), and nearly 70% Indian woman are said to be anaemic. It is important to treat anaemia with haematopoietic nutrients which include Iron along with Vitamin C, Folate and Vitamin B12.
- MNN Multi Micronutrients
- European Patent No. 0662825B1 provides various multi micronutrients to pregnant women in a trimester-wise administered formulation. Despite the effort taken to provide unique formulation for each trimester, it does not include nutritional elements which reduce pregnancy induced symptoms such as, morning sickness, leg-cramps, gestational diabetes, pre-eclampsia, gestational thyroid, constipation and gastro-intestinal side-effects, which are commonly experienced by most women during pregnancy. Thus, the prenatal supplementation remains incomplete in terms of providing a trimester-wise solution which is good for both mother and the baby. Secondly, it is recognized that various groups of human population need different types and quantities of micronutrients - based on their diet, genetics and commonly found deficiencies.
- the present invention overcomes the shortcomings of the prior art and provides a unique system and kit for nutritional supplementation to a pregnant woman, which comprises: a) a first composition comprising the following ingredients for the first trimester: vitamins A, Bl, B2, B3, B5, B6, B7, B9, B12, C, D, E, K; and Minerals, Zinc, Iodine, Magnesium, Molybdenum, Copper, Selenium, Manganese, Chromium, Boron; Omega; and Anti-emetic anti-nausea blend; (Optionally, Iron, Calcium, Choline, Inositol, Pre and Probiotics, and Amino acids) b) a second composition comprising the following ingredients for the second trimester: vitamins A, Bl, B2, B3, B5, B6, B7, B9, B12, C, D, E, K; and Minerals, Zinc, Iodine, Magnesium, Molybdenum, Copper, Selenium, Manganese, Chromium
- composition useful as nutritional supplement in the first trimester comprises a combination of: Vitamin A- 600-6000mcg, preferably 1600mcg;
- Vitamin B2- 0.2 to lOOmg, preferably 2mg
- Vitamin B7 - lOmcg to lOmg, preferably 30mcg;
- Vitamin D- 200-4000 IU preferably 400IU
- Zinc - 10-40mg preferably 12mg
- composition useful as nutritional supplement in the second trimester comprises a combination of:
- Vitamin A- 600-6000mcg preferably 1600mcg
- Vitamin D- 200-4000 IU preferably 400IU
- Zinc - 10-40mg preferably 12mg
- composition useful as nutritional supplement in the third trimester comprises a combination of:
- Vitamin A- 600-6000mcg preferably 1600mcg
- Vitamin B7 - lOmcg to lOmg, preferably 30mcg;
- Vitamin D- 200-4000 IU preferably 400IU
- Zinc - 10-40mg preferably 12mg
- the inventors after much study and research have found that the above unique combination of vitamins and minerals together with other supplements is useful in nourishing and maintaining the nutritional balance in a pregnant woman. It is notable that in each of the trimesters, the amount of vitamins and minerals is varied to meet the needs of the body, growing foetus, and manage the typical pregnancy symptoms of that trimester. The units of the vitamins and amount thereof is the result of careful and purposeful selection.
- Vitamin A is also an important element to be consumed for visual health, immune function and fetal growth and development. It is a known fact that most Indian women are deficient in Vitamin A. Vitamin A deficiency can cause visual impairment in the form of night blindness and may increase the risk of illness and death from childhood infections such as measles and diarrhea. The effects are seen much after the child is born. It is important for maintenance of mother’s eye health. Vitamin A along with Vitamins C and E, Manganese and Selenium act as antioxidants which prevents oxidative stress in mother during pregnancy. This reduces chances of foetal complications. Since high dose of Vitamin A is teratogenic, only 25% of the required dose is used for the supplement - the rest is consumed via a typical healthy diet.
- Vitamin A in the composition is present in as mixture of retinol and beta carotene. Vitamin A is at its highest during the third trimester of pregnancy due to accelerated fetal development and the physiological increase in blood volume during this period. Therefore, keeping all these factors in mind, the composition provides 600 -6,000 pg preferably 1600 pg during the entire course of pregnancy.
- Vitamin B
- vitamin B One of the most important vitamins to be taken during pregnancy is vitamin B often called vitamin B complex. It isa very important aspect of a mother’s nutrition during pregnancy, especially vitamins B6, B9, and B12. These three specifically help minimize the risk of birth defects as well as relieve some symptoms of pregnancy.
- Vitamin B complex (as is popularly known is a mixture of Vitamin Bl, B2 and B3) acts as coenzymes in several intermediary metabolic cellular pathways particularly for energy generation and blood cell formation. Therefore, vitamin B complex is required for release of energy in cells and also for the metabolism of protein, fat and carbohydrates. Vitamin B 12 functions with folate is essential for the methylation of DNA, RNA, proteins, neurotransmitters and phospholipids. Deficiency in these vitamins can therefore impact on cellular growth as well as on nerve tissue development. Vitamin B complex is essential for baby’s brain and spine; each of the vitamins help each other synergistically in the production of energy. Vitamin B complex along with copper helps in maternal and foetal brain development. The main source of vitamin B complex is animal product, nuts and vegetables. However, in a primarily vegetarian diet proper amount of vitamins are not available due to poor soil quality. Hence, to complete the required quantity, supplementation is required.
- B-l (Thiamine) Supports baby’s healthy brain development.
- the composition provides 1.6 mg, though it may be taken between 2-8mg. Since it is very important for the brain development, it is maintained constant throughout the pregnancy. It improves mother’s energy, mood and stress levels by aiding metabolism. In the baby it provides energy to the brain, helps in the formation of Red Blood Cells. It may be present in the range of 0.2 to 100 mg, preferably 1.6mg
- B-2 (Riboflavin): Keeps eyes healthy and skin glowing. In the first trimester, it is ideal to administer 0.2 to 100 mg; the composition provides 2mg, which is determined as ideal for proper skin development. It is maintained constant throughout the pregnancy.
- B-3 Niacin: It is important as it metabolizes carbohydrate to produce energy, helps in functioning of Central Nervous System, digestive system, skin health. In the first trimester, it is ideal to administer 2 to 35 mg; the composition provides 18 mg, it is maintained constant throughout the pregnancy.
- B-5 (Pantothenic Acid): Reduces leg cramps and helps produce essential pregnancy hormones. In the first trimester, it is ideal to administer 1-10 mg; the composition provides 5mg, which is determined as ideal for proper skin development. It is maintained constant throughout the pregnancy.
- B-6 Aids the development of baby’s nervous system and brain.
- the first trimester it is found to prevent vomiting and nausea. It also provides energy to the mother.
- the fetus it helps in formation of red blood cells and balances homocysteine levels.
- the first trimester it is ideal to administer 8-15 mg; the composition provides lOmg.
- the composition provides 3 mg.
- B-7 Biotin: Deficiency is often caused by pregnancy, so increased consumption is vital. In the first trimester, it helps with embryogenesis. It also helps in maintaining the hair and skin of the mother. It works synergistically with other B -vitamins in the production of energy. It is ideal to administer 10 pg - 10 mg; the composition provides 30 pg, which is determined as ideal for proper development of the fetus. It is maintained constant throughout the pregnancy at about 30 pg.
- B-9 (Folic Acid): Plays a vital role in reducing the risk of birth defects. In the first trimester, it supplements and eliminates deficiency, helps in prevention of neural tube defects. It also helps mother prevent anaemia and peripheral neuropathy. In the foetus it prevents congenital abnormalities. Vitamin B2, C and D along with Folate helps in better prevention of neural tube defects. Vitamin B9 is in the form of L-Methylfolate which is 7 times higher bioavailable then folic acid. Since most Indian females are folate deficient therefore supplementation of 5mg dietary folate is required in the first trimester. Thereafter, in second and third trimesters, for maintaining levels of folate 0.5mg dietary folate is sufficient.
- B-12 (Cobalamin): It maintains and supports the development of mother and baby’s nervous system. It also prevents Low birth weight and controls foetal brain development. In the first trimester, it is ideal to administer 0.25 - 1500 pg; the composition provides 3.6pg, which is determined as ideal for proper development of the fetus as well as provide energy and blood flow to the mother.
- Vitamin C is a water-soluble vitamin and powerful antioxidant which is essential as it a well- known immunity booster. It also plays an important role in the development of the foetus and reduces the risk of developing cardiovascular disease and certain cancers. It is important for tissue repair and wound healing, helps in development of child’s bones and teeth. Vitamin C also aids in the body’s production of collagen. Vitamin A along with Vitamins C and E, Manganese and Selenium act as antioxidants which prevent oxidative stress in mother during pregnancy. Thereby, reducing chances of foetal complications. Vitamin C when combined with Iron, improves its absorption. As per the invented composition, the amount may be 30- 200mg, preferably 60mg for each trimester.
- Vitamin D deficiency is a common problem in reproductive-aged women and has become a major public health problem worldwide. The effect of VDD in pregnancy has been associated with several adverse pregnancy outcomes. Lack of vitamin D or insufficient amount of vitamin D can not only result in poor bones for the children but also affect the children throughout their life. Such children are prone to osteoporosis. It improves calcium absorption and supports bone health of both mother and foetus. 400 IU is ideal maintenance doze for a pregnant woman. It can slowly build her Vitamin D reserve without causing any side-effects. If a certain woman is found deficient in Vitamin D, then she can be supplemented separately for a couple of weeks. In view of these factors, the composition of the invention employs vitamin D in an amount of 200-4000IU preferably 400 IU in each trimester.
- Vitamin E is necessary for reproduction. It is a powerful lipid-soluble antioxidant. Vitamin E helps your body create and maintain red blood cells, healthy skin, eyes and strengthens the natural immune system. Vitamin E helps to reduce the risk of pregnancy complications involving oxidative stress, such as pre-eclampsia. Boosts antioxidant defence and protects cell membrane. Enhances immune function. Helps clot formation in blood. Vitamin E works along with vitamin A, C, selenium and manganese as anti-oxidants. Keeping in view these objectives, the composition of the invention employs Vitamin E in an amount of 7-400mg preferably lOmg during each trimester.
- Vitamin K plays an important role in blood clotting, healthy bone development and protein formation in the liver. It is particularly important during labour. Vitamin K deficiency can lead to a haemorrhagic disease that increases the risk of child bleeding too much. It is essential for bone health, provides immune support to the mother and promotes healthy muscle function; protein formation in the liver. Vitamin K along with Vitamin D works together for calcium absorption bone development. During the third Trimester, it prevents excess blood loss during delivery. Keeping in view these objectives, the composition of the invention employs Vitamin K in an amount of 25-90mcg preferably, 55pg during each trimester.
- Zinc has a major role to play in body development and functioning of the mother and her foetus. Zinc can be naturally found in certain food items or consumed in the form of supplements. Zinc must be taken in its elemental form and not in form of any salt. It increases immunity when taken along with Vitamin C. It helps in the production of haemoglobin and also prevents preterm birth. It also helps in proper absorption of Vitamin A and Iron. Most Indians are zinc deficient due to agricultural deprivation of the nutrient. Maternal deprivation also leads to anaemic children. Therefore, Zinc supplementation is crucial in pregnancy. Zinc requirements during pregnancy is between 5-40 mg. In addition to the zinc accrued by the foetus, zinc is deposited in the placenta, amniotic fluid, and uterine and mammary tissue, hence the composition provides 12mg for each of the trimesters.
- Selenium is fat-soluble, but is very important for protecting the body from damage caused by free radicals and infections. This vital antioxidant helps regulate the immune system and thyroid function. Selenium is also essential for reproduction, and DNA production. It acts as an antioxidant; regulates immune response; and helps in functioning of Thyroid Hormone. It along with Vitamin A, C and E acts as anti-oxidant. Also, along with iodine helps in thyroid function. Keeping in view these objectives, the composition of the invention employs selenium in an amount of 30-70mcg, preferably 40mcg during each trimester.
- Manganese is an important mineral because it helps the growing foetus to form bone and cartilage. It acts as an antioxidant and prevents cell damage of both mother and foetus. Also helps in formation of bone and cartilage. It maintains overall energy level in the mother. Manganese along with Selenium, vitamin A, C and E act as an antioxidant and reduces oxidative stress. Supplementing Selenium and Manganese have long-range benefits, they protect babies from developing high blood pressure in their later years. Keeping in view these objectives, the composition of the invention employs manganese in an amount of 2-5 mg, preferably 4mg during each trimester.
- Chromium is important for the developing foetus as it helps with protein building in the tissues of the foetus. It plays an important role in the breakdown of lipids, carbohydrate, and protein. It stimulates fatty acid and cholesterol synthesis; they are important for brain function and other body processes. Therefore, chromium is an essential trace nutrient required during pregnancy for the health and well-being of both the mother and the developing foetus. Chromium along with Vitamin D helps in prevention of gestational diabetes. During pregnancy chromium becomes deficient putting pregnant female at risk of developing gestational diabetes. Keeping in view these objectives, the composition of the invention employs manganese in an amount of 20-100mcg, preferably 50 mcg during each trimester.
- Mg Magnesium
- Mg is a very important and essential mineral which is required by human body in substantially large amounts. It works with many enzymes to regulate body temperature, aids in synthesis nucleic acids, and proteins as well as maintaining electrical potentials in nerves and muscle membranes. It also has an important role in modulating vasomotor tone and cardiac excitability. Mg is sourced from dairy products, breads and cereals, legumes, vegetables, and meats etc. Processing of foods can lead to high depletion of Mg. During pregnancy, there is a greater need for magnesium than in a normal human.
- the composition of the invention as used in the first and second trimester contains 150- 300 mg magnesium, preferably 206 mg; while in the third trimester, the amount may be between 200-400 mg, preferably 306 mg.
- Molybdenum works in the body to break down proteins and other substances. Mineral involved in the functioning of several important enzymes in the body. It aids in carbohydrate and fat metabolism and helps in iron utilization. It contributes to normal sulphur amino acid metabolism. Vegetables and various animal products and fruits are low in molybdenum. Therefore, supplementation is required to fulfil the deficiency. Keeping in view these objectives, the composition of the invention employs molybdenum in an amount of 45 mcg during each trimester. Iron:
- the composition of the invention employs elemental iron from the second trimester in an amount of 12-100mg, preferably 60mg per day dose.
- the iron which is added in the composition is Time- Released, that is, it is released slowly in timed and sustained manner so that it is better absorbed and the woman does not suffer from constipation and black stools - which is a common side effect of high-dose iron supplementation.
- the composition of the invention employs elemental calcium from the second trimester, in an amount of 500-1200mg preferably 500mg per day dose.
- composition of the invention employs Boron in an amount of 100 mcg to lOmg preferably, 150 mcg.
- composition of the invention employs iodine between 100-300 pg, preferably 200 pg in all trimesters.
- Omega is important during pregnancy as they are critical building blocks of foetal brain and retina. Omega fatty acids may also play a role in determining the length of gestation and in preventing perinatal depression. Omega fatty acids has been shown to prevent pre-term labour and delivery, lower the risk of preeclampsia, and may increase birth weight. Omega deficiency also increases the mother's risk of post-natal depression. Keeping in view these objectives, the composition of the invention may haveOmega 3 (EPA and DHA in a ratio of 2:3) in an amount 50-1000mg, preferably lOOmg in first trimester, and 200mg in second and third trimester. It may also have Omega 6 and Omega 9 in an amount from 50-500 mg.
- Anti-emetic Blend containing natural extracts such as, Scutellaria baicalensis, Lemon and Citrus extracts, Ganoderma Lucidum, Zingiber Officinale, Grape seed extract, Mentha Spicata, Peppermint, Cinnamon etc. can help reduce symptoms of morning sickness without any side effects. It may be present in an amount 50-600mg preferably 200mg.
- a bowel regulator made from safe and natural ingredients, (such as, Hull lignans, Foeniculum vulgare, Senna Alexandrina, Zingiber Officinale, cuminum cyminum, Carum Carvi etc.) soothes their symptom and makes them feel better. It may be present in an amount 50-2000mg preferably, 200mg.
- UTI blend :
- It may be cranberry extract, hibiscus extract or D- manno sewhich possess Anti- adherence properties that prevent fimbriae Escherichia coli from adhering to uroepithelial cells in the urinary tract. It may be given in an amount 50- 800mg.
- Amino acids display important role for optimum foetal growth and other necessary functions for continuing fruitful pregnancy.
- Arginine, glutamine, tryptophan and taurine play a crucial role in foetal growth, development and survival while ornithine and proline are important players for the regulation of gene expression, protein synthesis and angiogenesis.
- Probiotic supplementation has been associated with prevention of gestational diabetes and mastitis. It may be present between 20-200mg.
- the inventors also noticed that there are some reactions caused by administration of one vitamin may affect the intake of other vitamins. For instance, while magnesium is important for absorption of vitamin D, the amount of magnesium intake is important. Sub-optimal amount may cause some adverse reactions [Advances in Nutrition, Volume 7, Issue 1, January 2016, Pages 25-43]. Similarly, excess amount of vitamin A can cause nausea, vomiting, dizziness, blurred vision, and poor muscle coordination etc. Some studies show that vitamin B6 has an adverse effect on phenytoin [https://www.uspharmacist.com/article/drug- interactions-with-vitamins-and-minerals]. Vitamins A and D when administered singly at high levels adversely affect bone metabolism.
- compositions and kit developed is synergistic.
- Iron is designed to be in Time-Release format - released at a certain period and suited for appropriate absorption by the body.
- Post Consumption of tablet 40% Iron is released within the first 2 hours, and subsequently 20% of Iron is released every 2 hours. Therefore, total Iron is released within 8 hours of consumption.
- the human body can only absorb only 12-18 mg of Iron at one time and rest of dose is known to pass the intestine without absorption thereby causing black stools, constipation and loss of nutrient material. In this case, when Iron is ‘Time-Released’ it ensures proper absorption of Iron in the body and causing minimum physiological sideeffects.
- the metals used in the composition may be in the form of slats. Any specific form of the salt may be used as long as it provides similar elemental or dietary values as described above.
- composition of the invention may be in the form of tablet, capsule, chewable or swallow able composition, (i.e. those that do not readily dissolve when placed in the mouth and may be swallowed whole without any chewing), in the form of a liquid syrup, powders, granules, effervescent tablets, mouth dissolving tablets or strips - or any other pharmaceutical delivery system. Tablet dosage form will be preferred.
- composition may be provided with a suitable film coating.
- the composition may employ suitable excipients and carriers such as polyvinylpyrrolidone, polyvinyl alcohol and acetate, cellulosics such as methyl and ethyl cellulose, hydroxyethyl cellulose and hydroxylpropyl methylcellulose, acrylates and methacrylates, copolymers such as the vinyl- maleic acid and styrene-maleic acid types, and natural gums and resins such as zein, gelatin, shellac and acacia etc.
- suitable excipients and carriers such as polyvinylpyrrolidone, polyvinyl alcohol and acetate, cellulosics such as methyl and ethyl cellulose, hydroxyethyl cellulose and hydroxylpropyl methylcellulose, acrylates and methacrylates, copolymers such as the vinyl- maleic acid and styrene-maleic acid types, and natural gums and resins
- the composition of the invention may also be formulated as a chewable composition having palatable taste and mouthfeel, are relatively soft and quickly disintegrates in the mouth.
- the chewable composition may include suitable favorants, sucralose, monoammonium glycyrrhizinate, flavor oils, anise oil, cinnamon oil, vanilla, vanillin, cocoa, chocolate, etc. as may be known to a person skilled in the art.
- compositions may be facilitated by including relatively small particles sizes of the ingredients used.
- any appropriate fillers and excipients may be utilized in preparing the swallow able, chewable and/or dissolvable compositions of the present invention so long as they are consistent with the objectives described herein.
- binders are substances used to cause adhesion of powder particles in granulations.
- Such compounds appropriate for use in the present invention include, by way of example and without limitation, acacia, compressible sugar, gelatin, sucrose and its derivatives, maltodextrin, cellulosic polymers, such as ethylcellulose, hydroxypropylcellulose, hydroxypropylmethyl cellulose, carbo xymethylcellulose sodium and methylcellulose, acrylic polymers, such as insoluble acrylate ammo nio methacrylate copolymer, polyacrylate or polymethacrylic copolymer, povidones, copovidones, polyvinylalcohols, alginic acid, sodium alginate, starch, pregelatinized starch, guar gum, polyethylene glycol and others known to those of ordinary skill in the art. Diluents, lubricants glidants, colorants may be included in the composition if desired.
- the kit may comprise 3 or more compositions for each trimester.
- Multi-micronutrient as used herein is a composition comprising various vitamins and minerals for treatment or prevention of specific micronutrient deficiency in pregnant women.
- Multi-Vitamin composition The following ingredients were used to prepare composition comprising multi-vitamin and multi-minerals during the first, second, and third trimesters of pregnancy:
- a study is undertaken to evaluate the effectiveness of the compositions of the present invention in the treatment of patients.
- the objective of the study is to determine whether oral intake of the compositions results in an improvement of the nutritional status of patients with regard to the specific vitamins and minerals contained in the administered compositions.
- the study was conducted in 5 patients over a period of 6 months. The 5 subjects were pregnant women in the first trimester of their pregnancy. None of them had any severe deficiencies or complications at the beginning of the study. They were administered on the trimester-wise composition for a period of 6 months - from the middle of the first trimester to second trimester to the middle of the third trimester. No other nutritional supplements were taken by the subjects during the assessment period except invented composition.
- the nutritional status of the patient has improved as compared to 1 st reading and maintained within ⁇ 5 margin.
- kits of the invention provides significant improvement in the nutritional health of the woman.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention provides a formulation of multi micronutrient (MMN) of 3 -stage course for each trimester of pregnancy comprising: vitamins and minerals for first trimester of pregnancy; vitamins and minerals for second trimester of pregnancy; and vitamins and minerals for third trimester of pregnancy. The present invention furthermore provides a kit having a formulation of multi micronutrient (MMN) of 3 -stage course for each trimester of pregnancy.
Description
MULTI MICRO-NUTRIENT (MMN); COMPOSITION FOR PREGNANCY
FIELD OF INVENTION
The present invention relates to a novel Multi Micro -nutrient (MMN) formulation and trimester- wise system for pregnant women, especially, women in India.
BACKGROUND OF THE INVENTION
Pregnancy places a high demand in terms of physiological needs of women. Nutritional intake during pregnancy not only determines growth and development of the fetus but also impacts the health of that child in his or her lifetime. In the baby, micronutrient deficiency during pregnancy, can lead to megaloblastosis, neural tube defects, placental and foetal defects, low birth weight and premature delivery. It has also been found that nutritional intake during pregnancy defines the mother’s well-being while she is pregnant as well as postdelivery. Nutritional deficiencies can cause various pregnancy symptoms such as gestational diabetes, preeclampsia, thyroid, leg cramps, insomnia, nausea, post-natal depression etc.; and can also lead to long-term issues in the mother such as osteoporosis, hypertension and diabetes.
On anaverage 20% to 30% of pregnant women suffer from a micronutrient deficiency without prophylaxis and about 75% would show a deficit of at least 2-3 micronutrients.
Vitamins and Minerals, together categorised as multi micronutrients, are commonly administered during pregnancy. The purpose is firstly, to treat micronutrient deficiencies in the pregnant woman; and secondly, to meet the increasing physiological demands by filling the gaps in her diet.
The role of the micronutrients in pregnancy is well established. Let’s take the case of Vitamin B complex, composed of eight B vitamins- vitamins Bi (thiamine), B2 (riboflavin), B3 (niacin), Be (pyridoxine) and B12 (cyanocobalamin), which are water-soluble vitamins required for the production and release of energy in cells and for the metabolism of macronutrients. These vitamins act as coenzymes in a number of enzyme-dependent cellular intermediary metabolic pathways for energy generation and blood cell formation. Vitamin B12 and folate convert homocysteine to methionine that is essential for the methylation of DNA, RNA, proteins, neurotransmitters and phospholipids and deficiency in these vitamins
can affect cellular growth and nerve tissue development. Studies have indicated that despite vitamin supplementation, deficiency of vitamin A, B6, niacin and thiamine may occur during all trimesters. B12 deficits increase during the second and third trimesters indicating that as pregnancy progresses the B12 demand by the foetus may be heightened.
Similarly, folate is a water-soluble B vitamin present in leafy green vegetables, yeast extract and citrus fruits such as oranges. Folic acid is most crucial in pregnancy from preconception until at least 12 weeks. Supplementation of folic acid during preconception and early pregnancy is critical and can prevent 40-80% of neural tube defects (NTDs) such as spina bifida. However, the dietary folic acid is converted to acid to L- methylfolate in the body through a number of enzymatic reactions and lastly using enzyme methyl-tetrahydrofolate reductase (MTHFR) before it can be absorbed by the body. It has been reported that about 40% to 60% of the population has genetic polymorphisms in the MTHFR gene and therefore are unable to convert supplemental folic acid to its active form, L- methylfolate. This can lead to pregnancy complications such as miscarriage, preeclampsia and birth defect. In fact, 80% women in India are folate deficient. Based on the available data of high prevalence of the genetic polymorphisms in MTHFR enzyme, using L-methly folate supplementation can help reduce blood folate deficiencies
Iron is another important micro -nutrient which is involved in number of important cellular processes. Iron is involved in synthesis of haemoglobin and myoglobin, including oxygen transport, respiration, growth, gene regulation, and the proper functioning of iron-dependent enzymes. Anaemia has been estimated to affect 40% of pregnant women globally, with the highest prevalence in the regions of South-east Asia (49%), and nearly 70% Indian woman are said to be anaemic. It is important to treat anaemia with haematopoietic nutrients which include Iron along with Vitamin C, Folate and Vitamin B12.
Clearly, the nutritional requirement of an expectant mother changes depending on the different geographical regions and the traditional food preference prevalent in a particular region. The diet of an average Indian, both in urban & rural sector, is known to be rich in carbohydrates but micronutrient deficient. It has been reported that one in two pregnant women intakes micronutrients below estimated average requirement. Therefore, micronutrient supplementation during pregnancy is suggested by doctors.
However, the formulations currently available are not nutritionally adequate to make up for the all deficiencies in the diet of an Indian expectant mother. Besides there is no product that can effectively provide the essential micronutrients in a one-stop system, forcing the doctors to prescribe many no. of micronutrient tablets separately (such as, folic acid, Iron, Calcium, Vitamin D, B-complex etc.). The increase in number of tablets is known to affect patient compliance. Infact, studies show that 40% patients show poor adherence to therapy when multiple pills are prescribed.
Apart from this, while an average Indian pregnant woman ends up taking 3-4 tablets/day, she continues to suffer from pregnancy induced symptoms like morning sickness, cramps, Urinary Tract Infection, diabetes, hypertension etc.; thereby, requiring further medication to resolve them. Too many medicines have their own side-effects such as bloating, burping, constipation etc. In essence, in spite of so many medications the 9-month journey of the pregnant mother is full of physiological discomfort and yet does not ensure her and the child’s wellbeing.
Keeping the above in view, there is a need to provide a comprehensive, multi Micronutrients (MMN) formulation that effectively provides all the essential multi micronutrients to the mother, ensuring her immediate and long-range wellbeing as well as the same for the child; and all the above to be provided in a simple one-stop package which ensures easy adherence to therapy.
European Patent No. 0662825B1 provides various multi micronutrients to pregnant women in a trimester-wise administered formulation. Despite the effort taken to provide unique formulation for each trimester, it does not include nutritional elements which reduce pregnancy induced symptoms such as, morning sickness, leg-cramps, gestational diabetes, pre-eclampsia, gestational thyroid, constipation and gastro-intestinal side-effects, which are commonly experienced by most women during pregnancy. Thus, the prenatal supplementation remains incomplete in terms of providing a trimester-wise solution which is good for both mother and the baby. Secondly, it is recognized that various groups of human population need different types and quantities of micronutrients - based on their diet, genetics and commonly found deficiencies. The above patent caters to the need of European population and does not address the needs of the Indian population. Thirdly, it overlooks the benefits of various important antioxidants such as Selenium and Manganese; trace minerals like Molybdenum, Boron, Chromium; and other nutrients like Vitamin K, Omega etc. - all,
which play a vital role in foetal brain and organ development, cognitive benefits, reducing the chances of birth defects and improving maternal health.
It would be therefore desirable to provide a multi-micronutrient supplementation which overcomes the deficiencies of the prior art.
DETAILED DESCRIPTION
The present invention overcomes the shortcomings of the prior art and provides a unique system and kit for nutritional supplementation to a pregnant woman, which comprises: a) a first composition comprising the following ingredients for the first trimester: vitamins A, Bl, B2, B3, B5, B6, B7, B9, B12, C, D, E, K; and Minerals, Zinc, Iodine, Magnesium, Molybdenum, Copper, Selenium, Manganese, Chromium, Boron; Omega; and Anti-emetic anti-nausea blend; (Optionally, Iron, Calcium, Choline, Inositol, Pre and Probiotics, and Amino acids) b) a second composition comprising the following ingredients for the second trimester: vitamins A, Bl, B2, B3, B5, B6, B7, B9, B12, C, D, E, K; and Minerals, Zinc, Iodine, Magnesium, Molybdenum, Copper, Selenium, Manganese, Chromium, Boron, Iron, Calcium; Omega; (Optionally, Choline, Inositol, Amino acids, Pre and Probiotics) c) a third composition comprising the following ingredients for the third trimester: vitamins A, Bl, B2, B3, B5, B6, B7, B9, B12, C, D, E, K; and Minerals, Zinc, Iodine, Magnesium, Molybdenum, Copper, Selenium, Manganese, Chromium, Boron, Iron, Calcium; Omega; and Bowel Regulator for constipation; (Optionally, Choline, Inositol, Amino acids, Pre and Probiotics, and Urinary Tract Infection blend)
In particular, the composition useful as nutritional supplement in the first trimester comprises a combination of:
Vitamin A- 600-6000mcg, preferably 1600mcg;
Vitamin Bl- 0.2 to lOOmg, preferably 1.6mg;
Vitamin B2- 0.2 to lOOmg, preferably 2mg;
Vitamin B3 - 2 to 35mg; preferably 18 mg;
Vitamin B5- l-10mg- preferably 5mg;
Vitamin B6 - 2-10 mg, preferably lOmg;
Vitamin B7 - lOmcg to lOmg, preferably 30mcg;
Vitamin B9- 0.2 to lOmg, preferably 5mg;
Vitamin B12- 0.2 to 1500 mcg, preferably 3.6mcg;
Vitamin C - 30-200 mg, preferably 60mg;
Vitamin D- 200-4000 IU, preferably 400IU;
Vitamin E - 7 to 400mg, preferably lOmg;
Vitamin K - 25-90 mcg, preferably 55mcg;
Zinc - 10-40mg preferably 12mg;
Iodine - 100-300pg, preferably 200pg;
Copper - l-2mg, preferably 1.7mg;
Selenium - 30-70 mcg, preferably 40mcg;
Manganese - 2-6 mg, preferably 4mg;
Chromium- 20-100 mcg, preferably 50mcg;
Molybdenum- 45mcg-2mg, preferably 45mcg;
Boron - lOOmcg -10 mg, preferably 150mcg;
Magnesium - 200-400 mg, preferably 206mg;
Omega3- 50-2000mg, preferably lOOmg;
Anti-emetic anti-nausea blend- 50mg-600mg, preferably 200mg;
Further, the composition useful as nutritional supplement in the second trimester comprises a combination of:
Vitamin A- 600-6000mcg, preferably 1600mcg;
Vitamin Bl- 0.2 to lOOmg, preferably 1.6mg;
Vitamin B2- 0.2 to 100 mg, preferably 2mg;
Vitamin B3 - 2 to 35mg; preferably 18 mg;
Vitamin B5- l-10mg- preferably 5mg;
Vitamin B6 - 2 -10 mg, preferably 3 mg;
Vitamin B7 - lOmcg to lOmg, preferably 30mcg;
Vitamin B9- 0.2 to lOmg, preferably 0.5mg;
Vitamin B12- 0.2 to 1500 mcg, preferably 3.6mcg;
Vitamin C - 30-200 mg, preferably 60mg;
Vitamin D- 200-4000 IU, preferably 400IU;
Vitamin E - 7 to 400mg, preferably lOmg;
Vitamin K - 25-90 mcg, preferably 55mcg;
Iodine - 100-300pg, preferably 200pg;
Zinc - 10-40mg preferably 12mg;
Copper - l-2mg, preferably 1.7mg;
Selenium - 30-70 mcg, preferably 40mcg;
Manganese - 2-6 mg, preferably 4mg;
Chromium- 20-100 mcg, preferably 50mcg;
Molybdenum- 45mcg-2mg, preferably 45mcg;
Boron - lOOmcg -10 mg, preferably 150mcg;
Magnesium - 200-400 mg, preferably 206mg;
Iron - 30-100 mg, preferably 60mg;
Calcium - 300-800 mg, preferably 500mg;
Omega 3- 50-2000mg, preferably 200mg;
Additionally, the composition useful as nutritional supplement in the third trimester comprises a combination of:
Vitamin A- 600-6000mcg, preferably 1600mcg;
Vitamin Bl- 0.2 to lOOmg, preferably 1.6mg;
Vitamin B2- 0.2 to 100 mg, preferably 2mg;
Vitamin B3 - 2 to 35mg; preferably 18 mg;
Vitamin B5- l-10mg- preferably 5mg;
Vitamin B6 - 2 -10 mg, preferably 3 mg;
Vitamin B7 - lOmcg to lOmg, preferably 30mcg;
Vitamin B9- 0.2 to lOmg, preferably 0.5mg;
Vitamin B12- 0.2 to 1500 mcg, preferably 3.6mcg;
Vitamin C - 30-200 mg, preferably 60mg;
Vitamin D- 200-4000 IU, preferably 400IU;
Vitamin E - 7 to 400mg, preferably lOmg;
Vitamin K - 25-90 mcg, preferably 55mcg;
Iodine - 100-300pg, preferably 200pg;
Zinc - 10-40mg preferably 12mg;
Copper - l-2mg, preferably 1.7mg;
Selenium - 30-70 mcg, preferably 40mcg;
Manganese - 2-6 mg, preferably 4mg;
Chromium- 20-100 mcg, preferably 50mcg;
Molybdenum- 45mcg-2mg, preferably 45mcg;
Boron - lOOmcg -10 mg, preferably 150mcg;
Magnesium - 200-400 mg, preferably 310mg;
Iron - 30-100 mg, preferably 60mg;
Calcium - 300-800 mg, preferably 500mg;
Omega 3- 50-2000mg, preferably 200mg;
Digestive blend- 50mg-600mg, preferably 200mg
The inventors after much study and research have found that the above unique combination of vitamins and minerals together with other supplements is useful in nourishing and maintaining the nutritional balance in a pregnant woman. It is notable that in each of the trimesters, the amount of vitamins and minerals is varied to meet the needs of the body, growing foetus, and manage the typical pregnancy symptoms of that trimester. The units of the vitamins and amount thereof is the result of careful and purposeful selection.
Vitamin A:
Vitamin A is also an important element to be consumed for visual health, immune function and fetal growth and development. It is a known fact that most Indian women are deficient in Vitamin A. Vitamin A deficiency can cause visual impairment in the form of night blindness and may increase the risk of illness and death from childhood infections such as measles and diarrhea. The effects are seen much after the child is born. It is important for maintenance of mother’s eye health. Vitamin A along with Vitamins C and E, Manganese and Selenium act as antioxidants which prevents oxidative stress in mother during pregnancy. This reduces chances of foetal complications. Since high dose of Vitamin A is teratogenic, only 25% of the required dose is used for the supplement - the rest is consumed via a typical healthy diet. Vitamin A in the composition is present in as mixture of retinol and beta carotene. Vitamin A is at its highest during the third trimester of pregnancy due to accelerated fetal development and the physiological increase in blood
volume during this period. Therefore, keeping all these factors in mind, the composition provides 600 -6,000 pg preferably 1600 pg during the entire course of pregnancy.
Vitamin B:
One of the most important vitamins to be taken during pregnancy is vitamin B often called vitamin B complex. It isa very important aspect of a mother’s nutrition during pregnancy, especially vitamins B6, B9, and B12. These three specifically help minimize the risk of birth defects as well as relieve some symptoms of pregnancy.
Vitamin B complex (as is popularly known is a mixture of Vitamin Bl, B2 and B3) acts as coenzymes in several intermediary metabolic cellular pathways particularly for energy generation and blood cell formation. Therefore, vitamin B complex is required for release of energy in cells and also for the metabolism of protein, fat and carbohydrates. Vitamin B 12 functions with folate is essential for the methylation of DNA, RNA, proteins, neurotransmitters and phospholipids. Deficiency in these vitamins can therefore impact on cellular growth as well as on nerve tissue development. Vitamin B complex is essential for baby’s brain and spine; each of the vitamins help each other synergistically in the production of energy. Vitamin B complex along with copper helps in maternal and foetal brain development. The main source of vitamin B complex is animal product, nuts and vegetables. However, in a primarily vegetarian diet proper amount of vitamins are not available due to poor soil quality. Hence, to complete the required quantity, supplementation is required.
B-l (Thiamine): Supports baby’s healthy brain development. In the first trimester, the composition provides 1.6 mg, though it may be taken between 2-8mg. Since it is very important for the brain development, it is maintained constant throughout the pregnancy. It improves mother’s energy, mood and stress levels by aiding metabolism. In the baby it provides energy to the brain, helps in the formation of Red Blood Cells. It may be present in the range of 0.2 to 100 mg, preferably 1.6mg
B-2 (Riboflavin): Keeps eyes healthy and skin glowing. In the first trimester, it is ideal to administer 0.2 to 100 mg; the composition provides 2mg, which is determined as ideal for proper skin development. It is maintained constant throughout the pregnancy.
B-3 (Niacin): It is important as it metabolizes carbohydrate to produce energy, helps in functioning of Central Nervous System, digestive system, skin health. In the first trimester, it is ideal to administer 2 to 35 mg; the composition provides 18 mg, it is maintained constant throughout the pregnancy.
B-5 (Pantothenic Acid): Reduces leg cramps and helps produce essential pregnancy hormones. In the first trimester, it is ideal to administer 1-10 mg; the composition provides 5mg, which is determined as ideal for proper skin development. It is maintained constant throughout the pregnancy.
B-6 (Pyridoxine): Aids the development of baby’s nervous system and brain. In the first trimester it is found to prevent vomiting and nausea. It also provides energy to the mother. In the fetus, it helps in formation of red blood cells and balances homocysteine levels. In the first trimester, it is ideal to administer 8-15 mg; the composition provides lOmg. In second and third trimester, it is ideal to administer 2 to 10 mg the composition provides 3 mg.
B-7 (Biotin): Deficiency is often caused by pregnancy, so increased consumption is vital. In the first trimester, it helps with embryogenesis. It also helps in maintaining the hair and skin of the mother. It works synergistically with other B -vitamins in the production of energy. It is ideal to administer 10 pg - 10 mg; the composition provides 30 pg, which is determined as ideal for proper development of the fetus. It is maintained constant throughout the pregnancy at about 30 pg.
B-9 (Folic Acid): Plays a vital role in reducing the risk of birth defects. In the first trimester, it supplements and eliminates deficiency, helps in prevention of neural tube defects. It also helps mother prevent anaemia and peripheral neuropathy. In the foetus it prevents congenital abnormalities. Vitamin B2, C and D along with Folate helps in better prevention of neural tube defects. Vitamin B9 is in the form of L-Methylfolate which is 7 times higher bioavailable then folic acid. Since most Indian females are folate deficient therefore supplementation of 5mg dietary folate is required in the first trimester. Thereafter, in second and third trimesters, for maintaining levels of folate 0.5mg dietary folate is sufficient.
B-12 (Cobalamin): It maintains and supports the development of mother and baby’s nervous system. It also prevents Low Birth weight and controls foetal brain development. In the first trimester, it is ideal to administer 0.25 - 1500 pg; the composition provides 3.6pg, which is
determined as ideal for proper development of the fetus as well as provide energy and blood flow to the mother.
Vitamin C:
Vitamin C is a water-soluble vitamin and powerful antioxidant which is essential as it a well- known immunity booster. It also plays an important role in the development of the foetus and reduces the risk of developing cardiovascular disease and certain cancers. It is important for tissue repair and wound healing, helps in development of child’s bones and teeth. Vitamin C also aids in the body’s production of collagen. Vitamin A along with Vitamins C and E, Manganese and Selenium act as antioxidants which prevent oxidative stress in mother during pregnancy. Thereby, reducing chances of foetal complications. Vitamin C when combined with Iron, improves its absorption. As per the invented composition, the amount may be 30- 200mg, preferably 60mg for each trimester.
Vitamin D:
Vitamin D deficiency (VDD) is a common problem in reproductive-aged women and has become a major public health problem worldwide. The effect of VDD in pregnancy has been associated with several adverse pregnancy outcomes. Lack of vitamin D or insufficient amount of vitamin D can not only result in poor bones for the children but also affect the children throughout their life. Such children are prone to osteoporosis. It improves calcium absorption and supports bone health of both mother and foetus. 400 IU is ideal maintenance doze for a pregnant woman. It can slowly build her Vitamin D reserve without causing any side-effects. If a certain woman is found deficient in Vitamin D, then she can be supplemented separately for a couple of weeks. In view of these factors, the composition of the invention employs vitamin D in an amount of 200-4000IU preferably 400 IU in each trimester.
Vitamin E:
Vitamin E is necessary for reproduction. It is a powerful lipid-soluble antioxidant. Vitamin E helps your body create and maintain red blood cells, healthy skin, eyes and strengthens the natural immune system. Vitamin E helps to reduce the risk of pregnancy complications involving oxidative stress, such as pre-eclampsia. Boosts antioxidant defence and protects cell membrane. Enhances immune function. Helps clot formation in blood. Vitamin E works
along with vitamin A, C, selenium and manganese as anti-oxidants. Keeping in view these objectives, the composition of the invention employs Vitamin E in an amount of 7-400mg preferably lOmg during each trimester.
Vitamin K:
Vitamin K plays an important role in blood clotting, healthy bone development and protein formation in the liver. It is particularly important during labour. Vitamin K deficiency can lead to a haemorrhagic disease that increases the risk of child bleeding too much. It is essential for bone health, provides immune support to the mother and promotes healthy muscle function; protein formation in the liver. Vitamin K along with Vitamin D works together for calcium absorption bone development. During the third Trimester, it prevents excess blood loss during delivery. Keeping in view these objectives, the composition of the invention employs Vitamin K in an amount of 25-90mcg preferably, 55pg during each trimester.
Zinc:
Zinc has a major role to play in body development and functioning of the mother and her foetus. Zinc can be naturally found in certain food items or consumed in the form of supplements. Zinc must be taken in its elemental form and not in form of any salt. It increases immunity when taken along with Vitamin C. It helps in the production of haemoglobin and also prevents preterm birth. It also helps in proper absorption of Vitamin A and Iron. Most Indians are zinc deficient due to agricultural deprivation of the nutrient. Maternal deprivation also leads to anaemic children. Therefore, Zinc supplementation is crucial in pregnancy. Zinc requirements during pregnancy is between 5-40 mg. In addition to the zinc accrued by the foetus, zinc is deposited in the placenta, amniotic fluid, and uterine and mammary tissue, hence the composition provides 12mg for each of the trimesters.
Copper:
Copper plays an important role in electron transport, neurotransmitter synthesis, collagen cross-linkage, and melatonin production and is an important factor in the coagulation cascade. Copper is absorbed by the proximal small intestines and transported to the liver. Toxicity associated with abnormal metabolism, as seen in Wilson’s disease, can result in excessive copper accumulation and deposition in many tissues. This can lead to cardiac
dysfunction, liver cirrhosis, pancreatic dysfunction and neurological abnormalities. During pregnancy also, trace amounts of copper is needed. Copper is essential for red blood cell formation, it helps form baby's heart, blood vessels, skeletal and nervous systems. It helps in production of melanin. Copper works with Iron in maintaining haemoglobin levels. Deficiency of copper leads to teratogenicity. Supplementation of copper helps the transportation of iron in the body. Keeping in view these objectives, the composition of the invention employs copper in an amount of l-2mg, preferably 1.7 mg during each trimester.
Selenium:
Selenium is fat-soluble, but is very important for protecting the body from damage caused by free radicals and infections. This vital antioxidant helps regulate the immune system and thyroid function. Selenium is also essential for reproduction, and DNA production. It acts as an antioxidant; regulates immune response; and helps in functioning of Thyroid Hormone. It along with Vitamin A, C and E acts as anti-oxidant. Also, along with iodine helps in thyroid function. Keeping in view these objectives, the composition of the invention employs selenium in an amount of 30-70mcg, preferably 40mcg during each trimester.
Manganese:
Manganese is an important mineral because it helps the growing foetus to form bone and cartilage. It acts as an antioxidant and prevents cell damage of both mother and foetus. Also helps in formation of bone and cartilage. It maintains overall energy level in the mother. Manganese along with Selenium, vitamin A, C and E act as an antioxidant and reduces oxidative stress. Supplementing Selenium and Manganese have long-range benefits, they protect babies from developing high blood pressure in their later years. Keeping in view these objectives, the composition of the invention employs manganese in an amount of 2-5 mg, preferably 4mg during each trimester.
Chromium:
Chromium is important for the developing foetus as it helps with protein building in the tissues of the foetus. It plays an important role in the breakdown of lipids, carbohydrate, and protein. It stimulates fatty acid and cholesterol synthesis; they are important for brain function and other body processes. Therefore, chromium is an essential trace nutrient required during pregnancy for the health and well-being of both the mother and the
developing foetus. Chromium along with Vitamin D helps in prevention of gestational diabetes. During pregnancy chromium becomes deficient putting pregnant female at risk of developing gestational diabetes. Keeping in view these objectives, the composition of the invention employs manganese in an amount of 20-100mcg, preferably 50 mcg during each trimester.
Magnesium:
Magnesium (Mg) is a very important and essential mineral which is required by human body in substantially large amounts. It works with many enzymes to regulate body temperature, aids in synthesis nucleic acids, and proteins as well as maintaining electrical potentials in nerves and muscle membranes. It also has an important role in modulating vasomotor tone and cardiac excitability. Mg is sourced from dairy products, breads and cereals, legumes, vegetables, and meats etc. Processing of foods can lead to high depletion of Mg. During pregnancy, there is a greater need for magnesium than in a normal human. Magnesium deficiency can lead to many important complications during pregnancy including gestational diabetes mellitus [GDM], pregnancy-induced hypertension [HTN], leg cramps, and preeclampsia. It is also associated with low birth weight of the child, intrauterine growth retardation [IUGR], and preterm birth. Magnesium helps to resolve leg-cramps, has a calming effect on the mother’s mind and benefits her sleep - commonly found issues in the third trimester. Therefore, the composition of the invention as used in the first and second trimester contains 150- 300 mg magnesium, preferably 206 mg; while in the third trimester, the amount may be between 200-400 mg, preferably 306 mg.
Molybdenum;
Molybdenum works in the body to break down proteins and other substances. Mineral involved in the functioning of several important enzymes in the body. It aids in carbohydrate and fat metabolism and helps in iron utilization. It contributes to normal sulphur amino acid metabolism. Vegetables and various animal products and fruits are low in molybdenum. Therefore, supplementation is required to fulfil the deficiency. Keeping in view these objectives, the composition of the invention employs molybdenum in an amount of 45 mcg during each trimester.
Iron:
Iron is important as it helps the body to produce more blood. During pregnancy, the blood volume doubles. In India, most women are iron deficient. An average pregnant woman needs about 30 mg of elemental iron per day to meet the new demands of extra blood volume, the developing placenta, and growing fetus. Having low blood volume can lead to complications during delivery and the postpartum period. Iron along with Vitamin B 12, Folate and magnesium helps in improving anemia. Vitamin C helps in better absorption of iron in the body. Keeping in view these objectives, the composition of the invention employs elemental iron from the second trimester in an amount of 12-100mg, preferably 60mg per day dose. Further, the iron which is added in the composition is Time- Released, that is, it is released slowly in timed and sustained manner so that it is better absorbed and the woman does not suffer from constipation and black stools - which is a common side effect of high-dose iron supplementation.
Calcium:
Calcium is important in building teeth and bones, calcium also keeps blood and muscles moving and helps your nerves send messages from the brain to the rest of the body. During pregnancy, in case the mother is deficient in calcium the body will utilise the calcium of the mother’s bones to ensure that the bones and teeth of the foetus are well developed. It is for this reason that pregnant women are often recommended to take calcium supplements. Calcium and magnesium help in maintaining blood pressure and therefore prevent hypertension and pre-eclampsia during pregnancy. Keeping in view these objectives, the composition of the invention employs elemental calcium from the second trimester, in an amount of 500-1200mg preferably 500mg per day dose. By ensuring such amount in the composition, the overall health of the pregnant women as well as their future wellbeing is ensured as these women would not suffer from osteoporosis or such conditions in their later years.
Boron:
Boron is as important as other elements. It can kill yeast that cause vaginal infections. It also has antioxidant effects. Boron is needed for optimal calcium metabolism, prevents bone loss. Keeping in view these objectives, the composition of the invention employs Boron in an amount of 100 mcg to lOmg preferably, 150 mcg.
Iodine:
During pregnancy, there is a high demand for iodine during pregnancy. During the first trimester, thyroid hormones for embryonic and foetal tissues rely exclusively on the available maternal hormones; hence, iodine deficiency in the mother may have a negative impact on prenatal development. Clinical studies have reported a relationship of iodine deficiency and maternal hypothyroxinaemia during pregnancy with impaired neurocognitive and psychological development of the children. To cater to these needs the composition of the invention employs iodine between 100-300 pg, preferably 200 pg in all trimesters.
Omega:
Omega is important during pregnancy as they are critical building blocks of foetal brain and retina. Omega fatty acids may also play a role in determining the length of gestation and in preventing perinatal depression. Omega fatty acids has been shown to prevent pre-term labour and delivery, lower the risk of preeclampsia, and may increase birth weight. Omega deficiency also increases the mother's risk of post-natal depression. Keeping in view these objectives, the composition of the invention may haveOmega 3 (EPA and DHA in a ratio of 2:3) in an amount 50-1000mg, preferably lOOmg in first trimester, and 200mg in second and third trimester. It may also have Omega 6 and Omega 9 in an amount from 50-500 mg.
Anti-emetic Anti-Nausea blend:
Anti-emetic Blend containing natural extractssuch as, Scutellaria baicalensis, Lemon and Citrus extracts, Ganoderma Lucidum, Zingiber Officinale, Grape seed extract, Mentha Spicata, Peppermint, Cinnamon etc. can help reduce symptoms of morning sickness without any side effects. It may be present in an amount 50-600mg preferably 200mg.
Bowel regulator:
This is added as it enhances peristaltic movement of intestine and thereby improves digestion during pregnancy A large no. of women suffer from constipation in the third trimester. A bowel regulator, made from safe and natural ingredients, (such as, Hull lignans, Foeniculum vulgare, Senna Alexandrina, Zingiber Officinale, cuminum cyminum, Carum Carvi etc.) soothes their symptom and makes them feel better. It may be present in an amount 50-2000mg preferably, 200mg.
UTI blend:
It may be cranberry extract, hibiscus extract or D- manno sewhich possess Anti- adherence properties that prevent fimbriae Escherichia coli from adhering to uroepithelial cells in the urinary tract. It may be given in an amount 50- 800mg.
Choline:
This is important for development of the foetus’s brain and spinal cord. It may be present in an amount 50-500mg.
Amino acids:
These are optional. Amino acids display important role for optimum foetal growth and other necessary functions for continuing fruitful pregnancy. Arginine, glutamine, tryptophan and taurine play a crucial role in foetal growth, development and survival while ornithine and proline are important players for the regulation of gene expression, protein synthesis and angiogenesis.
Prebiotics and probiotics:
Probiotic supplementation has been associated with prevention of gestational diabetes and mastitis. It may be present between 20-200mg.
Inositol:
It helps in conception and managing of gestational diabetes. It may be present between 100
- lOOOmg.
The inventors also noticed that there are some reactions caused by administration of one vitamin may affect the intake of other vitamins. For instance, while magnesium is important for absorption of vitamin D, the amount of magnesium intake is important. Sub-optimal amount may cause some adverse reactions [Advances in Nutrition, Volume 7, Issue 1, January 2016, Pages 25-43]. Similarly, excess amount of vitamin A can cause nausea, vomiting, dizziness, blurred vision, and poor muscle coordination etc. Some studies show that vitamin B6 has an adverse effect on phenytoin [https://www.uspharmacist.com/article/drug- interactions-with-vitamins-and-minerals]. Vitamins A and D when administered singly at
high levels adversely affect bone metabolism. However, simultaneous administration of both vitamins at high levels will apparently diminish the toxic effects of each; High levels of dietary vitamin E are also believed to interact with vitamins D and K. It is because of these interactions of the vitamins with each other that the composition of the invention has been developed after much research on each vitamin and their reactions with each as well as with minerals and the proportion chosen is designed to avoid deleterious effects and provide positive nutritional effect. Thus, the compositions and kit developed is synergistic.
Further, in the composition of the invention, Iron is designed to be in Time-Release format - released at a certain period and suited for appropriate absorption by the body. Post Consumption of tablet, 40% Iron is released within the first 2 hours, and subsequently 20% of Iron is released every 2 hours. Therefore, total Iron is released within 8 hours of consumption. Typically, the human body can only absorb only 12-18 mg of Iron at one time and rest of dose is known to pass the intestine without absorption thereby causing black stools, constipation and loss of nutrient material. In this case, when Iron is ‘Time-Released’ it ensures proper absorption of Iron in the body and causing minimum physiological sideeffects.
The metals used in the composition may be in the form of slats. Any specific form of the salt may be used as long as it provides similar elemental or dietary values as described above.
The composition of the invention may be in the form of tablet, capsule, chewable or swallow able composition, (i.e. those that do not readily dissolve when placed in the mouth and may be swallowed whole without any chewing), in the form of a liquid syrup, powders, granules, effervescent tablets, mouth dissolving tablets or strips - or any other pharmaceutical delivery system. Tablet dosage form will be preferred.
Additionally, the composition may be provided with a suitable film coating. The composition may employ suitable excipients and carriers such as polyvinylpyrrolidone, polyvinyl alcohol and acetate, cellulosics such as methyl and ethyl cellulose, hydroxyethyl cellulose and hydroxylpropyl methylcellulose, acrylates and methacrylates, copolymers such as the vinyl- maleic acid and styrene-maleic acid types, and natural gums and resins such as zein, gelatin, shellac and acacia etc.
The composition of the invention may also be formulated as a chewable composition having palatable taste and mouthfeel, are relatively soft and quickly disintegrates in the mouth. The
chewable composition may include suitable favorants, sucralose, monoammonium glycyrrhizinate, flavor oils, anise oil, cinnamon oil, vanilla, vanillin, cocoa, chocolate, etc. as may be known to a person skilled in the art.
Finally, dissolution of the compositions may be facilitated by including relatively small particles sizes of the ingredients used. In addition to those described above, any appropriate fillers and excipients may be utilized in preparing the swallow able, chewable and/or dissolvable compositions of the present invention so long as they are consistent with the objectives described herein. For example, binders are substances used to cause adhesion of powder particles in granulations. Such compounds appropriate for use in the present invention include, by way of example and without limitation, acacia, compressible sugar, gelatin, sucrose and its derivatives, maltodextrin, cellulosic polymers, such as ethylcellulose, hydroxypropylcellulose, hydroxypropylmethyl cellulose, carbo xymethylcellulose sodium and methylcellulose, acrylic polymers, such as insoluble acrylate ammo nio methacrylate copolymer, polyacrylate or polymethacrylic copolymer, povidones, copovidones, polyvinylalcohols, alginic acid, sodium alginate, starch, pregelatinized starch, guar gum, polyethylene glycol and others known to those of ordinary skill in the art. Diluents, lubricants glidants, colorants may be included in the composition if desired.
In an embodiment, the kit may comprise 3 or more compositions for each trimester.
For the purpose of promoting an understanding of the principles of the invention, reference will be made to the embodiments. It will nevertheless be understood that no limitation of the scope of the invention is thereby intended, such alterations and further modifications in the illustrated system, and such further applications of the principles of the invention as illustrated therein being contemplated as would normally occur to one skilled in the art to which the invention relates.
It will be understood by those skilled in the art that the foregoing general description and the following detailed description are explanatory of the invention and are not intended to be restrictive thereof.
Reference throughout this specification to “an aspect”, “another aspect” or similar language means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment of the present invention. Thus, appearances of the phrase “in an embodiment”, “in another embodiment” and similar
language throughout this specification may, but do not necessarily, all refer to the same embodiment.
The terms "comprises", "comprising", or any other variations thereof, are intended to cover a non-exclusive inclusion, such that a process or method that comprises a list of steps does not include only those steps but may include other steps not expressly listed or inherent to such process or method. Similarly, one or more devices or sub-systems or elements or structures or components proceeded by "comprises... a" does not, without more constraints, preclude the existence of other devices or other sub- systems or other elements or other structures or other components or additional devices or additional sub-systems or additional elements or additional structures or additional components.
Multi-micronutrient (MMN) as used herein is a composition comprising various vitamins and minerals for treatment or prevention of specific micronutrient deficiency in pregnant women.
Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skilled in the art to which this invention belongs. The system, methods, and examples provided herein are illustrative only and not intended to be limiting.
The invention is illustrated by the following examples which are not to be treated as the only illustrations of the invention and any obvious modification would be deemed to fall within the scope of the invention.
EXAMPLE
Preparation of Multi-Vitamin composition- The following ingredients were used to prepare composition comprising multi-vitamin and multi-minerals during the first, second, and third trimesters of pregnancy:
A study is undertaken to evaluate the effectiveness of the compositions of the present invention in the treatment of patients. The objective of the study is to determine whether oral intake of the compositions results in an improvement of the nutritional status of patients with regard to the specific vitamins and minerals contained in the administered compositions.
The study was conducted in 5 patients over a period of 6 months. The 5 subjects were pregnant women in the first trimester of their pregnancy. None of them had any severe deficiencies or complications at the beginning of the study. They were administered on the trimester-wise composition for a period of 6 months - from the middle of the first trimester to second trimester to the middle of the third trimester. No other nutritional supplements were taken by the subjects during the assessment period except invented composition.
An assessment of the nutritional status of each woman was conducted at various intervals for a six-month period. A statistically significant improvement in the nutritional status of various vitamin and mineral levels measured is observed in the treated subjects over the controls upon completion of the study. Therefore, the study confirms that oral administration of the compositions of the present invention is effective in improving the nutritional status of patients.
As evident from the table above, the nutritional status of the patient has improved as compared to 1st reading and maintained within ± 5 margin.
A second study was undertaken in 20 pregnant women for eight months beginning from their first trimester to the third trimester - to assess the effect of the composition of the invention on the symptomatic relief observed in patients after consuming the trimester-wise composition for the entire 3 trimesters. The results are tabulated below:
As seen from the above table 9 of 10 women reported no morning sickness; 7/10 reported low frequency of leg cramps, 8/10 reported no Bloating and Burping and GI,7/10 reported Less Constipation and Black stool, 9/10 reported Less Fatigue, energy and mood swings, 8/10 reported Normal Blood Pressure, 7/10 reported normal blood glucose levels in first, second and third trimesters.
This was a double blinded randomized controlled two arm study with one group treated with the present invention composition and the other with placebo, in addition to the standard of care treatment. Each group had 10 women and the baseline parameters like age, weight and blood pressure were insignificantly different between groups. Majority of the women in either group were without any history of complications. Thus, the kit of the invention provides significant improvement in the nutritional health of the woman.
Although the present invention has been described in considerable detail with reference to certain preferred embodiments thereof, other obvious variants are possible and may be easily devised by a person skilled in the art. Therefore, the spirit and scope of the appended claims is not intended to be limited to the description and the preferred embodiments set out within this specification.
While specific embodiments of the present invention have been described, other and further modifications and changes may be made without departing from the spirit of the invention. All further and other modifications and changes are included that come within the scope of
the invention as set forth in the claims. The disclosure of all publications cited above are expressly incorporated by reference in their entireties to the same extent as if each were incorporated by reference individually.
Claims
1. A kit of nutritional supplements to pregnant women, which comprises: a) a first composition comprising the following ingredients for the first trimester: vitamins A, Bl, B2, B3, B5, B6, B7, B9, B12, C, D, E, K; and Minerals, Zinc, Iodine, Magnesium, Molybdenum, Copper, Selenium, Manganese, Chromium, Boron; Omega; and Anti-emetic anti-nausea blend; b) a second composition comprising the following ingredients for the second trimester: vitamins A, Bl, B2, B3, B5, B6, B7, B9, B12, C, D, E, K; and Minerals, Zinc, Iodine, Magnesium, Molybdenum, Copper, Selenium, Manganese, Chromium, Boron, Iron, Calcium; Omega; c) a third composition comprising the following ingredients for the third trimester: vitamins A, Bl, B2, B3, B5, B6, B7, B9, B12, C, D, E, K; and Minerals, Zinc, Iodine, Magnesium, Molybdenum, Copper, Selenium, Manganese, Chromium, Boron, Iron, Calcium; Omega; and Bowel Regulator for constipation;
2. A kit as claimed in claim 1 wherein the composition for the first trimaster additionally comprises Iron, Calcium, Choline, Inositol, Pre and Probiotics, and Amino acids.
3. A kit as claimed in claim 1 wherein the composition for the second trimester further comprises Choline, Inositol, Amino acids, Pre and Probiotics.
4. A kit as claimed in claim 1 wherein the composition for the third trimester further comprises (Optionally, Choline, Inositol, Amino acids, Pre and Probiotics, and Urinary Tract Infection blend.
25
A composition useful as nutritional supplement in the first trimester comprising a combination of:
Vitamin A- 600-6000mcg, preferably 1600mcg;
Vitamin Bl- 0.2 to lOOmg, preferably 1.6mg;
Vitamin B2- 0.2 to lOOmg, preferably 2mg;
Vitamin B3 - 2 to 35mg; preferably 18 mg;
Vitamin B5- l-10mg- preferably 5mg;
Vitamin B6 - 2 -10 mg, preferably lOmg;
Vitamin B7 - lOmcg to lOmg, preferably 30mcg;
Vitamin B9- 0.2 to lOmg, preferably 5mg;
Vitamin B12- 0.2 to 1500 mcg, preferably 3.6mcg;
Vitamin C - 30-200 mg, preferably 60mg;
Vitamin D- 200-4000 IU, preferably 400IU;
Vitamin E - 7 to 400mg, preferably lOmg;
Vitamin K - 25-90 mcg, preferably 55mcg;
Zinc - 10-40mg preferably 12mg;
Iodine - 100-300pg, preferably 200pg;
Copper - l-2mg, preferably 1.7mg;
Selenium - 30-70 mcg, preferably 40mcg;
Manganese - 2-6 mg, preferably 4mg;
Chromium- 20-100 mcg, preferably 50mcg;
Molybdenum- 45mcg-2mg, preferably 45mcg;
Boron - lOOmcg -10 mg, preferably 150mcg;
Magnesium - 200-400 mg, preferably 206mg;
Omega 3 - 50-2000mg, preferably lOOmg;
Anti-emetic anti-nausea blend- 50mg-600mg, preferably 200mg;
Together with nutritionally acceptable excipients; A composition as claimed in claim 5 comprising a combination of:
Vitamin A- 1600mcg;
Vitamin Bl- 1.6mg;
Vitamin B2- 2 mg;
Vitamin B3 -18mg;
Vitamin B5- 5mg;
Vitamin B6 -lOmg;
Vitamin B7 -30mcg;
Vitamin B9- 5mg;
Vitamin B12- 3.6mcg;
Vitamin C -60mg;
Vitamin D- 400IU;
Vitamin E -lOmg;
Vitamin K -55 mcg;
Zinc - 12mg;
Iodine -200|ig;
Copper -1.7mg;
Selenium -40mcg;
Manganese -4 mg;
Chromium-50mcg ;
Molybdenum-45mcg;
Boron -150mcg;
Magnesium -206mg;
Omega 3 - lOOmg;
Anti-emetic anti-nausea blend- 200mg;
Together with nutritionally acceptable excipients. A composition useful as nutritional supplement in the second trimester comprising a combination of:
Vitamin A- 600-6000mcg, preferably 1600mcg;
Vitamin Bl- 0.2 to lOOmg, preferably 1.6mg;
Vitamin B2- 0.2 to 100 mg, preferably 2mg;
Vitamin B3 - 2 to 35mg; preferably 18 mg;
Vitamin B5- l-10mg- preferably 5mg;
Vitamin B6 - 2 -10 mg, preferably 3 mg;
Vitamin B7 - lOmcg to lOmg, preferably 30mcg;
Vitamin B9- 0.2 to lOmg, preferably 0.5mg;
Vitamin B12- 0.2 to 1500 mcg, preferably 3.6mcg;
Vitamin C - 30-200 mg, preferably 60mg;
Vitamin D- 200-4000 IU, preferably 400IU;
Vitamin E - 7 to 400mg, preferably lOmg;
Vitamin K - 25-90 mcg, preferably 55mcg;
Iodine - 100-300pg, preferably 200pg;
Zinc - 10-40mg preferably 12mg;
Copper - l-2mg, preferably 1.7mg;
Selenium - 30-70 mcg, preferably 40mcg;
Manganese - 2-6 mg, preferably 4mg;
Chromium- 20-100 mcg, preferably 50mcg;
Molybdenum- 45mcg-2mg, preferably 45mcg;
Boron - lOOmcg -10 mg, preferably 150mcg;
Magnesium - 200-400 mg, preferably 206mg;
Iron - 30-100 mg, preferably 60mg;
Calcium - 300-800 mg, preferably 500mg;
Omega 3- 50-2000mg, preferably 200mg; together with nutritionally acceptable carriers. A composition as claimed in claim 7 wherein the composition comprises:
Vitamin A- 1600mcg;
Vitamin Bl- 1.6mg;
Vitamin B2- 2mg;
Vitamin B3 -18mg;
Vitamin B5- 5mg;
Vitamin B6 -3 mg;
Vitamin B7 -30mcg;
Vitamin B9- 0.5mg;
Vitamin B12- 3.6mcg;
Vitamin C -60mg;
Vitamin D- 400IU;
Vitamin E -lOmg;
Vitamin K -55 mcg;
Iodine -200pg;
Zinc -12mg;
Copper -1.7mg;
Selenium -40mcg;
Manganese -4 mg;
Chromium-50mcg ;
Molybdenum-45mcg;
28
Boron -150mcg;
Magnesium -206mg;
Iron - 60mg;
Calcium -500mg;
Omega 3- 200mg; together with nutritionally acceptable carriers. A composition useful as nutritional supplement in the third trimester comprises a combination of:
Vitamin A- 600-6000 mcg, preferably 1600mcg;
Vitamin Bl- 0.2 to lOOmg, preferably 1.6mg;
Vitamin B2- 0.2 to 100 mg, preferably 2mg;
Vitamin B3 - 2 to 35mg; preferably 18 mg;
Vitamin B5- l-10mg- preferably 5mg;
Vitamin B6 - 2 -10 mg, preferably 3 mg;
Vitamin B7 - lOmcg to lOmg, preferably 30mcg;
Vitamin B9- 0.2 to lOmg, preferably 0.5mg;
Vitamin B12- 0.2 to 1500 mcg, preferably 3.6mcg;
Vitamin C - 30-200 mg, preferably 60mg;
Vitamin D- 200-4000 IU, preferably 400IU;
Vitamin E - 7 to 400mg, preferably lOmg;
Vitamin K - 25-90 mcg, preferably 55mcg;
Iodine - 100-300pg, preferably 200pg;
Zinc - 10-40mg preferably 12mg;
Copper - l-2mg, preferably 1.7mg;
Selenium - 30-70 mcg, preferably 40mcg;
Manganese - 2-6 mg, preferably 4mg;
Chromium- 20-100 mcg, preferably 50mcg;
Molybdenum- 45mcg-2mg, preferably 45mcg;
Boron - lOOmcg -10 mg, preferably 150mcg;
Magnesium - 200-400 mg, preferably 310mg;
Iron - 30-100 mg, preferably 60mg;
Calcium - 300-800 mg, preferably 500mg;
Omega 3- 50-2000mg, preferably 200mg;
Digestive blend- 50mg-600mg, preferably 200mg;
29
together with nutritionally acceptable carriers. A composition as claimed in claim 9 wherein the composition comprises:
Vitamin A- 1600mcg;
Vitamin Bl- 1.6mg;
Vitamin B2- 2mg;
Vitamin B3 -18mg;
Vitamin B5- 5mg;
Vitamin B6 -3 mg;
Vitamin B7 -30mcg;
Vitamin B9- 0.5mg;
Vitamin B12- 3.6mcg;
Vitamin C -60mg;
Vitamin D- 400IU;
Vitamin E -lOmg;
Vitamin K -55 mcg;
Iodine -200pg;
Zinc -12mg;
Copper -1.7mg;
Selenium -40mcg;
Manganese -4 mg;
Chromium-50mcg ;
Molybdenum-45mcg;
Boron -150mcg;
Magnesium -3 lOmg;
Iron -60mg;
Calcium -500mg;
Omega 3- 200mg;
Digestive blend- 200mg; together with nutritionally acceptable carriers.
30
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN202111003434 | 2021-01-25 | ||
IN202111003434 | 2021-01-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022157745A1 true WO2022157745A1 (en) | 2022-07-28 |
Family
ID=82548717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2022/050634 WO2022157745A1 (en) | 2021-01-25 | 2022-01-25 | Multi micro-nutrient (mmn): composition for pregnancy |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2022157745A1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040101554A1 (en) * | 1999-05-27 | 2004-05-27 | Drugtech Corporation | Nutritional formulations |
WO2014016627A1 (en) * | 2012-07-25 | 2014-01-30 | Baby-Med Professional Company | Vitamin and mineral preparations for gravidae for use in trimesters of pregnancy |
-
2022
- 2022-01-25 WO PCT/IB2022/050634 patent/WO2022157745A1/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040101554A1 (en) * | 1999-05-27 | 2004-05-27 | Drugtech Corporation | Nutritional formulations |
WO2014016627A1 (en) * | 2012-07-25 | 2014-01-30 | Baby-Med Professional Company | Vitamin and mineral preparations for gravidae for use in trimesters of pregnancy |
Non-Patent Citations (1)
Title |
---|
CHRISTINA ET AL.: "Vitamin and Mineral Supplementation during Pregnancy on Maternal, Birth, Child Health and Development Outcomes in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis", NUTRIENTS, vol. 12, no. 2, 14 February 2020 (2020-02-14), pages 491, XP055957513, DOI: 10.3390/nu12020491 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5574561B2 (en) | Total enteral nutrition composition | |
CN103238897B (en) | Composite plant solid drink suitable for diabetic patients | |
US6299896B1 (en) | Multi-vitamin and mineral supplement | |
US7572462B2 (en) | Peri-operative and peri-procedure nutritional supplementation | |
US6953588B2 (en) | Multi-vitamin and mineral supplement | |
US20030050341A1 (en) | Vitamin/Mineral Compositions with DHA | |
US20020044961A1 (en) | Nutritional formulations | |
AU2010206796B2 (en) | Nutritional supplements for 50+ individuals for improving vitality, immunity, eye and bone health | |
JP2010506882A (en) | Long-term enteral nutrition for maintenance | |
CN107028191B (en) | Vitamin composition suitable for accurate nutrition of middle-aged and elderly people | |
CN108391811A (en) | A kind of tumour full nutrition formula food and its application | |
EP2076256B1 (en) | Meal replacement compositions and weight control method | |
CN101366868A (en) | Medicament composition for preventing birth defect, improving memory and intelligence | |
CN101396419A (en) | Medicine composition for preventing the birth defect and improving the memory | |
WO2022157745A1 (en) | Multi micro-nutrient (mmn): composition for pregnancy | |
CN107106603A (en) | Orally taken product | |
CN114173580A (en) | Food composition for weight management | |
CN107125769A (en) | Metabolism operation nutrition in postoperative supplement compound formulation | |
WO2020128876A1 (en) | Composition comprising iodine; selenium, vitamin d3 and lycopene for the prevention and treatment of hypothyroidism | |
CN110800996A (en) | Special clinical nutrition formula for vomiting of pregnancy and preparation method thereof | |
Class et al. | ViralChoice Zinc+ C Chewable tablets | |
WITAMINOWO-MINERALNA et al. | DIETARY INTERVENTION OR VITAMIN AND MINERAL SUPPLEMENTATION DURING PREGNANCY? | |
Ghosh | VITAMINS IN PREGNANCY | |
WO2021108527A1 (en) | Dietary supplement | |
CN101422482A (en) | Medicine composition for preventing the birth defect and improving the memory |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22742365 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 22742365 Country of ref document: EP Kind code of ref document: A1 |